Share data

Share this page

Share data

Listings in the U.S. and Europe

QIAGEN’s common shares have been registered and traded in the United States since 1996 on the NASDAQ Global Select Market (NASDAQ National Market prior to July 2006) and in Germany since 1997 on the Frankfurt Stock Exchange (and the Prime Standard segment since its launch in 2003). Dual listing on NASDAQ and the Frankfurt Stock Exchange offers advantages for QIAGEN, our shareholders and employees since dual listing increases the potential market opportunity and increases liquidity for our shares. Unlike American Depositary Receipts (ADRs), QIAGEN’s shares provide equal corporate rights for all shareholders and can be traded on either exchange, in U.S. dollars or euros.

NASDAQ 2016 2015
Year-end price  $28.02 $27.65
High $28.84 $28.53
Low $19.94 $22.11
Average daily trading volume (in million shares) 1.0 0.9
Frankfurt Stock Exchange (XETRA) 2016 2015
Year-end price  €26.68 €25.12
High €27.26 €26.05
Low €17.76 €18.72
Average daily trading volume (in million shares) 0.4 0.4

Index Membership

QIAGEN is one of the largest and most prominent constituents of Germany’s TecDAX, a stock index that tracks the 30 largest German companies from the technology sector not included in the benchmark DAX index. As of December 31, 2016, QIAGEN was among the top three companies in the TexDAX based on market capitalization.

QIAGEN is also a member of the U.S. large-cap Russell 1000 index and the broad market Russell 3000 index, which measures performance of the 3,000 largest companies in the U.S. The Russell 1000 index is a subset of the Russell 3000 index and includes 1,000 of the largest securities based on a combination of their market capitalization and current index membership.

Furthermore, QIAGEN shares are included in other U.S. and European stock market indexes.

Key share data 2016 2015
Total equity (in $ thousands) 2,607,096 2,568,070 
Issued shares (in thousands)  239,707 239,707
Outstanding shares at December 31 (in thousands) 234,561 233,006
Weighted-average number of common shares outstanding - basic (in thousands) 234,800 233,483
Weighted-average number of common shares outstanding - diluted (in thousands) 238,993 238,647
Year-end market capitalization (in $ million) 6,572 6,443
Year-end market capitalization (in € million) 6,258 5,852